First human tests begin for potential kidney disease drug
NCT ID NCT07022119
Summary
This early-stage study is testing the safety of an experimental drug called VX-407 in healthy volunteers. Researchers want to understand how the body processes the medication and what side effects might occur. The results will help determine if VX-407 is safe enough to test in people with autosomal dominant polycystic kidney disease (ADPKD) in future studies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ICON Lenexa
Lenexa, Kansas, 66219, United States
Conditions
Explore the condition pages connected to this study.